270 related articles for article (PubMed ID: 10793824)
1. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
Ali NA; al-Naama LM; Khalid LO
East Mediterr Health J; 1999 May; 5(3):457-64. PubMed ID: 10793824
[TBL] [Abstract][Full Text] [Related]
2. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
Beutler E; Duparc S;
Am J Trop Med Hyg; 2007 Oct; 77(4):779-89. PubMed ID: 17978087
[TBL] [Abstract][Full Text] [Related]
3. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
[TBL] [Abstract][Full Text] [Related]
4. The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
Wang YM; Patterson JH; Van Eys J
J Clin Invest; 1971 Jul; 50(7):1421-8. PubMed ID: 4397414
[TBL] [Abstract][Full Text] [Related]
5. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
Ganesan S; Chaurasiya ND; Sahu R; Walker LA; Tekwani BL
Toxicology; 2012 Mar; 294(1):54-60. PubMed ID: 22330256
[TBL] [Abstract][Full Text] [Related]
6. [Formate incubation of red blood cells from glucose-6-phosphate-dehydrogenase-deficient patients].
Grieger M; Schippel W; Siems W; Leppin K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):704-15. PubMed ID: 6198254
[TBL] [Abstract][Full Text] [Related]
7. Red cell glucose-6-phosphate dehydrogenase phenotypes in Iraq.
Hilmi FA; Al-Allawi NA; Rassam M; Al-Shamma G; Al-Hashimi A
East Mediterr Health J; 2002 Jan; 8(1):42-8. PubMed ID: 15330559
[TBL] [Abstract][Full Text] [Related]
8. Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs.
Hohl RJ; Kennedy EJ; Frischer H
J Lab Clin Med; 1991 Apr; 117(4):325-31. PubMed ID: 1901343
[TBL] [Abstract][Full Text] [Related]
9. [Dissimilar glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in the Afars and the Somalis of Djibouti].
Sidrak W; Fox E; Polycarpe D; Olson JG; Shakib SO; Parra JP; Rodier G
Med Trop (Mars); 1991; 51(2):211-4. PubMed ID: 1895921
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential.
Magon A; Leipzig RM; Bloom K; Brewer GJ
Prog Clin Biol Res; 1981; 55():709-24. PubMed ID: 7291202
[TBL] [Abstract][Full Text] [Related]
11. Pro-oxidative effects of Chinese herbal medicine on G6PD-deficient erythrocytes in vitro.
Ko CH; Li K; Ng PC; Fung KP; Wong RP; Chui KM; Gu GJ; Yung E; Fok TF
Toxicol In Vitro; 2008 Aug; 22(5):1222-7. PubMed ID: 18515042
[TBL] [Abstract][Full Text] [Related]
12. Henna: a potential cause of oxidative hemolysis and neonatal hyperbilirubinemia.
Zinkham WH; Oski FA
Pediatrics; 1996 May; 97(5):707-9. PubMed ID: 8628611
[TBL] [Abstract][Full Text] [Related]
13. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
Bashan N; Peleg N; Moses SW
Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
[No Abstract] [Full Text] [Related]
14. Epidemiological, clinical and laboratory profile of glucose-6-phosphate dehydrogenase deficiency in the middle and north of Iraq: a comparative study.
Al-Mendalawi MD
East Mediterr Health J; 2010 Aug; 16(8):846-50. PubMed ID: 21469566
[TBL] [Abstract][Full Text] [Related]
15. Haemolytic effect of two sulphonamides evaluated by a new method.
Gaetani GD; Mareni C; Ravazzolo R; Salvidio E
Br J Haematol; 1976 Feb; 32(2):183-91. PubMed ID: 1247492
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced anemia.
Beutler E
Fed Proc; 1972; 31(1):141-6. PubMed ID: 4333249
[No Abstract] [Full Text] [Related]
17. Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan.
Choudhry VP; Ghafary A; Zaher M; Qureshi MA; Fazel I; Ghani R
Ann Trop Paediatr; 1990; 10(4):335-8. PubMed ID: 1708959
[TBL] [Abstract][Full Text] [Related]
18. [Determination of glucose-6-phosphate dehydrogenase deficiency to prevent possible drug-induced hemolysis].
Hadad Meléndez P; Martínez JL; Millán Marcelo JC; Aguiar Cruz F
Rev Cubana Med Trop; 1991; 43(3):205. PubMed ID: 9768192
[No Abstract] [Full Text] [Related]
19. [Hemolysis and primaquine treatment. Preliminary report].
Menéndez Capote R; Díaz Pérez L; Luzardo Suárez C
Rev Cubana Med Trop; 1997; 49(2):136-8. PubMed ID: 9685977
[TBL] [Abstract][Full Text] [Related]
20. [Clinical laboratory indices of hemolysis in persons with various types of haptoglobin in preventive primaquine therapy of malaria].
Shcherbakov AM; Ozeretskovskaia NN; Bronshteĭn AM; Benediktov II; Lachinova RI
Med Parazitol (Mosk); 1975; 44(3):288-92. PubMed ID: 1177820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
